Skip to main content
Caplight Logo









BioMark IQ

BioMark IQ

Private
PuneHealthcare & Life Scienceshttps://www.biomarkiq.com/

Last Round

Seed

Nov 1, 2023

Total Funding Raised

$30,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

BioMark IQ is a biotechnology company that develops an AI-powered in-vitro diagnostic platform for the early detection of lung cancer using non-invasive biomarker testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

lung cancer screeningliquid biopsybiomarker analysismedical AIearly cancer detectionprecision medicinediagnostic toolAI diagnosticshealthcare analyticsclinical decision supportpathology workflowresearch softwarenon-invasive testingbiotech startuphealthtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioMark IQ Comparables

Compare BioMark IQ with similar companies based on industry and business-model similarity.

BioMark IQ comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Datar Cancer Genetics
77%
Delfi Diagnostics
75%
20/20 BioLabs
72%

BioMark IQ Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 1, 2023
GrantAug 1, 2023

Key People

Founding team and executive leadership

Manasi Kulkarni-Khasnis

Co-Founder and Chief Executive Officer

Founding Team

BioMark IQ Investors

Notable investors and investment history

BioMark IQ investors
InvestorRounds
Nidhi Prayas (Department of Science and Technology)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 493% to 6.4K.

  • Apr 16, 2026

    Monthly visitors increased 81% MoM.

BioMark IQ Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioMark IQ Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioMark IQ's valuation, stock price, and market status.

Firmographic Details

HeadquartersPune
Employee Range15
Year Founded2023
Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?